Briacell Therapeutics Corp (BCTX) Stock Price, Quote & News

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 921 1810

Fax: 604 921 1898

Website: briacell.com

Address:

Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

JediGreen Mar. 3 at 3:46 AM

$BCTX I hope I can bank on this. Hopefully double my money. If I end up coming out of this with 200k or more I’m eyeballing a nice looking dividend stock that I’d be able to leave my 9 to 5 just on dividends a year. Come On BCTX do your magic free me.

0 · Reply

NeverBearTrader2025 Mar. 2 at 10:28 PM

$BCTX Waooo....did the P3 readout happen?

3 · Reply

MollyWantsACracker Mar. 2 at 7:36 PM

$BCTX In the green now.

0 · Reply

Kirubin Mar. 2 at 3:28 PM

$BCTX look at that!

1 · Reply

JediGreen Feb. 27 at 4:32 PM

$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2854) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-02-12-11-00-00/index.html

4 · Reply

OfficialStocktwitsUser Feb. 27 at 3:09 PM

$BCTX RSI: 39.31, MACD: -0.4976 Vol: 0.20, MA20: 4.09, MA50: 5.67 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

NeverBearTrader2025 Feb. 27 at 1:34 PM

$BCTX Group is quiet. Windoering if the readout will be good. I have only 2k shares but the energy on this board is not encouraging.

1 · Reply

tbagoni Feb. 26 at 10:34 PM

$BCTX Looking good since I said it hit bottom! 🤞

3 · Reply

Itsybitsybeanbag Feb. 26 at 9:35 PM

$BCTX NASDAQ Delisted haha

3 · Reply

Rohtan Feb. 26 at 2:44 AM

$BCTX one of the most craziest stock which I have been a part of past few years. It was CAS $2K per share in 2022. Can’t believe it.

1 · Reply

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

Wed, 18 Feb 2026 17:30:00 -0500 - 12 days ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

Tue, 17 Feb 2026 07:30:00 -0500 - 13 days ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2026-01-28T13:30:56.000Z - 4 weeks ago

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

Wed, 28 Jan 2026 07:30:00 -0500 - 4 weeks ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

2026-01-27T13:32:37.000Z - 4 weeks ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

Tue, 27 Jan 2026 07:30:00 -0500 - 4 weeks ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

2026-01-19T16:00:45.000Z - 6 weeks ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-16T13:58:57.000Z - 6 weeks ago

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

Thu, 15 Jan 2026 16:05:00 -0500 - 6 weeks ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

2026-01-14T11:36:30.000Z - 6 weeks ago

What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:19:44.000Z - 6 weeks ago

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

2026-01-14T10:55:53.000Z - 6 weeks ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T06:56:44.000Z - 6 weeks ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

2026-01-14T06:35:20.000Z - 6 weeks ago

BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit

2026-01-14T06:35:20.000Z - 6 weeks ago

BriaCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit

Tue, 13 Jan 2026 21:00:00 -0500 - 6 weeks ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

2026-01-13T20:32:32.000Z - 6 weeks ago

BCTX Surges On Positive Clinical Response In Metastatic Cancer Immunotherapy Study

2026-01-13T14:08:02.000Z - 6 weeks ago

BriaCell Surge Above 50%; What's The Buzz?

2026-01-13T12:53:09.000Z - 6 weeks ago

BriaCell (BCTX) Reports Impressive Lung Metastasis Resolution in Cancer Trial

Tue, 13 Jan 2026 07:30:00 -0500 - 6 weeks ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Thu, 18 Dec 2025 07:30:00 -0500 - 2 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

2025-12-10T13:29:00.000Z - 2 months ago

BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposium

Wed, 10 Dec 2025 07:30:00 -0500 - 2 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

2025-12-09T13:34:16.000Z - 2 months ago

BriaCell (BCTX) Progresses with Phase 3 Study in Metastatic Breast Cancer

Tue, 09 Dec 2025 07:30:00 -0500 - 2 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

2025-12-02T12:50:27.000Z - 3 months ago

BriaCell (BCTX) Shares Positive Clinical Results Ahead of 2025 Symposium

Tue, 02 Dec 2025 07:30:00 -0500 - 3 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

2025-12-01T12:53:14.000Z - 3 months ago

Bicara Therapeutics (BCTX) Releases Promising Early Data from Cancer Drug Trial

Tue, 25 Nov 2025 07:30:00 -0500 - 3 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

2025-11-20T13:28:07.000Z - 3 months ago

BriaCell (BCTX) Partners with Receptor.AI for Innovative Cancer Drug Development

Thu, 20 Nov 2025 07:30:00 -0500 - 3 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Tue, 18 Nov 2025 07:30:00 -0500 - 3 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Fri, 07 Nov 2025 07:30:00 -0500 - 4 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Tue, 04 Nov 2025 07:30:00 -0500 - 4 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

2025-10-28T08:01:00.000Z - 4 months ago

Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding

2025-10-27T19:05:00.000Z - 4 months ago

Top 3 Earnings Acceleration Buys for November

2025-10-22T12:51:17.000Z - 4 months ago

BriaCell (BCTX) Receives Positive Safety Endorsement for Phase 3 Cancer Study

Wed, 22 Oct 2025 07:30:00 -0400 - 4 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

2025-10-21T20:52:14.000Z - 4 months ago

BriaCell Rises On Phase 3 Expansion And MSK Collaboration

2025-10-21T13:25:38.000Z - 4 months ago

BriaCell (BCTX) Expands Phase 3 Cancer Study with New Major Centers

2025-10-21T12:50:54.000Z - 4 months ago

BriaCell (BCTX) Partners with MSK for Cancer Immunotherapy Development

Tue, 21 Oct 2025 07:50:00 -0400 - 4 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Tue, 21 Oct 2025 07:30:00 -0400 - 4 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

2025-10-20T13:31:42.000Z - 4 months ago

BriaCell (BCTX) Reports Promising Biomarker Data in Phase 3 Breast Cancer Study

Mon, 20 Oct 2025 07:30:00 -0400 - 4 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

2025-10-13T13:27:39.000Z - 5 months ago

BriaCell (BCTX) to Present Key Phase 3 Study Data at ESMO Congress 2025

Mon, 13 Oct 2025 07:30:00 -0400 - 5 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Fri, 03 Oct 2025 07:30:00 -0400 - 5 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

2025-09-12T16:00:02.000Z - 6 months ago

All You Need to Know About BRIACELL THERAP (BCTX) Rating Upgrade to Buy

Aug 26, 2025, 7:30 AM EDT - 6 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 25, 2025, 7:30 AM EDT - 6 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 21, 2025, 12:00 PM EDT - 6 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 13, 2025, 7:30 AM EDT - 7 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Jul 31, 2025, 7:30 AM EDT - 7 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 30, 2025, 7:30 AM EDT - 7 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 29, 2025, 7:30 AM EDT - 7 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 25, 2025, 7:30 AM EDT - 7 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 16, 2025, 4:05 PM EDT - 8 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 8 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 7:30 AM EDT - 8 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 8 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 10, 2025, 7:30 AM EDT - 8 months ago

BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in “Eye-Bulging” Breast Cancer Patient

Jul 9, 2025, 7:30 AM EDT - 8 months ago

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

Jul 8, 2025, 7:30 AM EDT - 8 months ago

BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer

Jul 2, 2025, 7:30 AM EDT - 8 months ago

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Jun 24, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

Jun 4, 2025, 7:30 AM EDT - 9 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

Jun 2, 2025, 7:30 AM EDT - 9 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

May 27, 2025, 7:30 AM EDT - 9 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

May 23, 2025, 7:30 AM EDT - 10 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

May 20, 2025, 7:30 AM EDT - 10 months ago

BriaCell CEO Letter to Shareholders

Apr 30, 2025, 7:30 AM EDT - 10 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

Apr 28, 2025, 4:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

Apr 28, 2025, 7:30 AM EDT - 11 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Apr 24, 2025, 8:00 PM EDT - 11 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

Apr 24, 2025, 10:11 AM EDT - 11 months ago

Nano-Cap BriaCell Confirms Full Resolution Of Lung Metastasis In Breast Cancer Trial, Stock Shoots Higher

Apr 24, 2025, 7:30 AM EDT - 11 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

Apr 23, 2025, 7:30 AM EDT - 11 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

JediGreen Mar. 3 at 3:46 AM

0 · Reply

NeverBearTrader2025 Mar. 2 at 10:28 PM

$BCTX Waooo....did the P3 readout happen?

3 · Reply

MollyWantsACracker Mar. 2 at 7:36 PM

$BCTX In the green now.

0 · Reply

Kirubin Mar. 2 at 3:28 PM

$BCTX look at that!

1 · Reply

JediGreen Feb. 27 at 4:32 PM

$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2854) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-02-12-11-00-00/index.html

4 · Reply

OfficialStocktwitsUser Feb. 27 at 3:09 PM

0 · Reply

NeverBearTrader2025 Feb. 27 at 1:34 PM

$BCTX Group is quiet. Windoering if the readout will be good. I have only 2k shares but the energy on this board is not encouraging.

1 · Reply

tbagoni Feb. 26 at 10:34 PM

$BCTX Looking good since I said it hit bottom! 🤞

3 · Reply

Itsybitsybeanbag Feb. 26 at 9:35 PM

$BCTX NASDAQ Delisted haha

3 · Reply

Rohtan Feb. 26 at 2:44 AM

$BCTX one of the most craziest stock which I have been a part of past few years. It was CAS $2K per share in 2022. Can’t believe it.

1 · Reply

MollyWantsACracker Feb. 25 at 9:56 PM

$BCTX In the green now, my ave is $3.80.

0 · Reply

Rohtan Feb. 25 at 9:31 PM

$BCTX I don’t like it but I had to buy some this morning at 5.11

1 · Reply

TopCharts Feb. 25 at 8:05 PM

$BCTX back on my watch!

0 · Reply

tbagoni Feb. 25 at 1:58 PM

$BCTX Think we hit bottom!

1 · Reply

JediGreen Feb. 25 at 7:57 AM

$BCTX Renmark Virtual Non-Deal Roadshow: TSX - BCT | NASDAQ - BCTX (ID 2854) https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-02-12-11-00-00/index.html

0 · Reply

GoldenChic Feb. 25 at 7:10 AM

$BCTX laughing at idiots pumping this for their daily trades

1 · Reply

BillionerOfKing Feb. 25 at 2:45 AM

$BCTX Current Stock Price: $3.65

0 · Reply

Firstvik Feb. 24 at 10:30 PM

$BCTX That there are still pumpers here is wild ..reminds me of '22

0 · Reply

Kirubin Feb. 24 at 4:57 PM

$BCTX clueless 🐑🐑🐑🐑🐑! Go against the market and you will always lose your shirt!

2 · Reply

Ares77manoe Feb. 24 at 1:19 PM

$BCTX lol

1 · Reply

JediGreen Feb. 24 at 8:05 AM

$BCTX I honestly would not doubt if this starts moving upwards after theses warrants expire and might see the big boys start to move in.

1 · Reply

JediGreen Feb. 24 at 7:42 AM

$BCTX From what I’m gathering You got BCTW warrants expiring in like 2 days BCTXZ with an exercise price around $52 and not many of them and the new ones BCTXL with like 5.5 million of those. So I’m estimating like all the total amount of possible shares if these warrants hit there prices wold be around 13 million shares all together that’s after BCTXW expires in like 2 days. Around 13 million shares all together. If we get positive phase 3 results with only around 13 million shares all together I definitely cold see this doing something special. So around 13 million shares what king of gap up and all the people stuck in this at higher prices yet do you guys think this could possibly gap up to. Feel free to reply.

4 · Reply

Market Cap	27.70M
Revenue (ttm)	0.00
Net Income (ttm)	-26.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	310,900
Avg Vol	524,206
Day's Range	N/A - N/A
Shares Out	7.25M
Stochastic %K	76%
Beta	1.42
Analysts	Strong Buy
Price Target	$40.00